André Perey

André Perey

(416) 862-6775
(416) 802-9974
100 King St W, Suite 6200, 1 First Cdn Pl, PO Box 50, Toronto, ON
Year called to bar: 1996 (ON)
André is a partner in the Emerging and High Growth Companies Practice in Osler’s Toronto Office. His practice focuses on M&A, startups and venture capital financing. André advises a broad range of foreign and Canadian clients operating in various industries, including software, digital media, online commerce, financial services, retail, food & beverage and renewable energy. André represents emerging and growth stage businesses, and strategic and financial investors in and acquirers of such businesses, and he is involved in numerous local and national innovation, incubator and business accelerator initiatives. André regularly advises foreign companies investing in or establishing Canadian ventures and helps structure, negotiate and implement a variety of complex commercial contracts involving the development, licensing and acquisition of intellectual property and technology. He has developed expertise in international joint venture transactions and has assisted clients in incorporating and investing in new ventures and related governance matters. André represents several domestic and international investment funds in connection with their Canadian activities. 
André Perey is a featured Leading Lawyer in:
Canadian Legal Lexpert Directory
Repeatedly Recommended
Canadian Legal Lexpert Directory
Repeatedly Recommended
Canadian Legal Lexpert Directory
Repeatedly Recommended
Canadian Legal Lexpert Directory
Repeatedly Recommended
André Perey is also listed in the following publication(s)
Read more about André Perey in ...
On September 30, 2018, Datix Limited (“Datix”), a global leader in patient safety, quality, and infection prevention, completed its acquisition of RL Solutions, a leading provider of healthcare quality and patient safety software.
On March 21, 2016, a group led by Norwest Venture Partners and including Georgian Partners and BMO Financial Group acquired a significant equity interest in Medgate Inc.